U.S. NIH Halts Clinical Trials in India, Cites Uncertainty Over Compensation Rules

International Pharmaceutical Regulatory Monitor
A A
The U.S. National Institutes of Health announced June 29 that it is withdrawing clinical trial research in India, and some experts are pointing to recent stringent regulations as a possible cause.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00